Related references
Note: Only part of the references are listed.Detection of Brain Tumor Cells in the Peripheral Blood by a Telomerase Promoter-Based Assay
Kelly M. MacArthur et al.
CANCER RESEARCH (2014)
p75 Neurotrophin Receptor Cleavage by α- and γ- Secretases Is Required for Neurotrophin-mediated Proliferation of Brain Tumor-initiating Cells
Peter A. Forsyth et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Methodological challenges in utilizing miRNAs as circulating biomarkers
Leni Moldovan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2014)
Tumor-Associated Circulating MicroRNAs as Biomarkers of Cancer
Jin Wang et al.
MOLECULES (2014)
Targeting Notch signaling pathway in cancer: Clinical development advances and challenges
Naoko Takebe et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Suberoylanilide hydroxamic acid (SAHA) causes tumor growth slowdown and triggers autophagy in glioblastoma stem cells
Ming-Tsang Chiao et al.
AUTOPHAGY (2013)
Anticancer Effects of Niclosamide in Human Glioblastoma
Anja Wieland et al.
CLINICAL CANCER RESEARCH (2013)
Anti-cancer Therapies in High Grade Gliomas
Cristiana Tanase et al.
Current Proteomics (2013)
Identification of seven serum microRNAs from a genome-wide serum microRNA expression profile as potential noninvasive biomarkers for malignant astrocytomas
Cuihua Yang et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Exosome Uptake Depends on ERK1/2-Heat Shock Protein 27 Signaling and Lipid Raft-mediated Endocytosis Negatively Regulated by Caveolin-1
Katrin J. Svensson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Netrin-1-induced activation of Notch signaling mediates glioblastoma cell invasion
Irene Ylivinkka et al.
JOURNAL OF CELL SCIENCE (2013)
Blood-based biomarkers for malignant gliomas
Matthias Holdhoff et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
A Systematic Review of MicroRNA in Glioblastoma Multiforme: Micro-modulators in the Mesenchymal Mode of Migration and Invasion
Heidi G. Moller et al.
MOLECULAR NEUROBIOLOGY (2013)
Cytokine Patterns in Brain Tumour Progression
Radu Albulescu et al.
MEDIATORS OF INFLAMMATION (2013)
Exploratory investigation of eight circulating plasma markers in brain tumor patients
Aysegul Ilhan-Mutlu et al.
NEUROSURGICAL REVIEW (2013)
Evidence for Post-Translational Processing of Vascular Endothelial (VE)-Cadherin in Brain Tumors: Towards a Candidate Biomarker
Isabelle Vilgrain et al.
PLOS ONE (2013)
Cytokines associated with toxicity in the treatment of recurrent glioblastoma with aflibercept
Nicole Shonka et al.
TARGETED ONCOLOGY (2013)
Inhibition of CXCL12/CXCR4 autocrine/paracrine loop reduces viability of human glioblastoma stem-like cells affecting self-renewal activity
Monica Gatti et al.
TOXICOLOGY (2013)
In Vitro and In Vivo Analysis of RTK Inhibitor Efficacy and Identification of Its Novel Targets in Glioblastomas
Olga Martinho et al.
TRANSLATIONAL ONCOLOGY (2013)
Nuclear Exclusion of TET1 Is Associated with Loss of 5-Hydroxymethylcytosine in IDH1 Wild-Type Gliomas
Tim Mueller et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
miRNAs as important drivers of glioblastomas: A no-brainer?
Andre Odjele et al.
CANCER BIOMARKERS (2012)
Plasma MicroRNA-21 Concentration May Be a Useful Biomarker in Glioblastoma Patients
Ayseguel Ilhan-Mutlu et al.
CANCER INVESTIGATION (2012)
Phase I Pharmacologic and Pharmacodynamic Study of the Gamma Secretase (Notch) Inhibitor MK-0752 in Adult Patients With Advanced Solid Tumors
Ian Krop et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Phase I Study of RO4929097, a Gamma Secretase Inhibitor of Notch Signaling, in Patients With Refractory Metastatic or Locally Advanced Solid Tumors
Anthony W. Tolcher et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Decrease in circulating endothelial progenitor cells in treated glioma patients
Elena Corsini et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Identification of Retinol Binding Protein 1 Promoter Hypermethylation in Isocitrate Dehydrogenase 1 and 2 Mutant Gliomas
Arthur P. Chou et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2012)
High level of miR-221/222 confers increased cell invasion and poor prognosis in glioma
Chunzhi Zhang et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2012)
Defining the mode of tumour growth by clonal analysis
Gregory Driessens et al.
NATURE (2012)
Pro-neural miR-128 is a glioma tumor suppressor that targets mitogenic kinases
T. Papagiannakopoulos et al.
ONCOGENE (2012)
Decreased 5-Hydroxymethylcytosine Is Associated with Neural Progenitor Phenotype in Normal Brain and Shorter Survival in Malignant Glioma
Brent A. Orr et al.
PLOS ONE (2012)
Proteins with Altered Levels in Plasma from Glioblastoma Patients as Revealed by iTRAQ-Based Quantitative Proteomic Analysis
Poonam Gautam et al.
PLOS ONE (2012)
Resistance to EGF receptor inhibitors in glioblastoma mediated by phosphorylation of the PTEN tumor suppressor at tyrosine 240
Tim R. Fenton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Investigation of serum proteome alterations in human glioblastoma multiforme
Kishore Gollapalli et al.
PROTEOMICS (2012)
Constitutive Notch2 signaling in neural stem cells promotes tumorigenic features and astroglial lineage entry
J. S. Tchorz et al.
CELL DEATH & DISEASE (2012)
Loss of heterozygosity analysis in malignant gliomas
Masahiro Mizoguchi et al.
BRAIN TUMOR PATHOLOGY (2011)
Expression of the new CXCL12 receptor, CXCR7, in gliomas
Chiara Calatozzolo et al.
CANCER BIOLOGY & THERAPY (2011)
Circulating Tumor Cell Isolation and Diagnostics: Toward Routine Clinical Use
Anja van de Stolpe et al.
CANCER RESEARCH (2011)
The Phosphoinositide 3-Kinase Signaling Pathway as a Therapeutic Target in Grade IV Brain Tumors
K. Hoeland et al.
CURRENT CANCER DRUG TARGETS (2011)
Circulating tumor cells: approaches to isolation and characterization
Min Yu et al.
JOURNAL OF CELL BIOLOGY (2011)
Chemokines at the crossroads of tumor-fibroblast interactions that promote malignancy
Pravin Mishra et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2011)
Glioblastoma-derived spheroid cultures as an experimental model for analysis of EGFR anomalies
Monika Witusik-Perkowska et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Circulating markers of angiogenesis, inflammation, and coagulation in patients with glioblastoma
Gaspar Reynes et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
Longitudinal prospective study of matrix metalloproteinase-9 as a serum marker in gliomas
Fabio M. Iwamoto et al.
JOURNAL OF NEURO-ONCOLOGY (2011)
A specific miRNA signature in the peripheral blood of glioblastoma patients
Patrick Roth et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas
Fabio M. Iwamoto et al.
NEURO-ONCOLOGY (2011)
Identification of novel synergistic targets for rational drug combinations with PI3 kinase inhibitors using siRNA synthetic lethality screening against GBM
Yong-Wan Kim et al.
NEURO-ONCOLOGY (2011)
Proteomics of gliomas: Initial biomarker discovery and evolution of technology
Juliya Kalinina et al.
NEURO-ONCOLOGY (2011)
MicroRNA miR-93 promotes tumor growth and angiogenesis by targeting integrin-β8
L. Fang et al.
ONCOGENE (2011)
Today's discoveries to tomorrow's care: cancer biomarkers revisited
Charles J. Rosser et al.
BIOMARKERS IN MEDICINE (2010)
Glioma Pathophysiology: Insights Emerging from Proteomics
Ruth F. Deighton et al.
BRAIN PATHOLOGY (2010)
Identification and Functional Characterization of microRNAs Involved in the Malignant Progression of Gliomas
Bastian Malzkorn et al.
BRAIN PATHOLOGY (2010)
Exciting New Advances in Neuro-Oncology The Avenue to a Cure for Malignant Glioma
Erwin G. Van Meir et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Circulating Levels of the Innate and Humoral Immune Regulators CD14 and CD23 Are Associated with Adult Glioma
Mi Zhou et al.
CANCER RESEARCH (2010)
microRNA-34a is tumor suppressive in brain tumors and glioma stem cells
Fadila Guessous et al.
CELL CYCLE (2010)
Phase II Study of Cediranib, an Oral Pan-Vascular Endothelial Growth Factor Receptor Tyrosine Kinase Inhibitor, in Patients With Recurrent Glioblastoma
Tracy T. Batchelor et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Proteomic Identification of Haptoglobin α2 as a Glioblastoma Serum Biomarker: Implications in Cancer Cell Migration and Tumor Growth
Durairaj Mohan Kumar et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Decoding signalling networks by mass spectrometry-based proteomics
Chunaram Choudhary et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)
Elevated blood markers 1 year before manifestation of malignant glioma
Wolfgang Gartner et al.
NEURO-ONCOLOGY (2010)
Serum DNA can define tumor-specific genetic and epigenetic markers in gliomas of various grades
Iris Lavon et al.
NEURO-ONCOLOGY (2010)
Crosstalk Between the PI3K/mTOR and MEK/ERK Pathways Involved in the Maintenance of Self-Renewal and Tumorigenicity of Glioblastoma Stem-Like Cells
Jun Sunayama et al.
STEM CELLS (2010)
Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy
Jian-Mei Hou et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Isocitrate Dehydrogenase 1 Codon 132 Mutation Is an Important Prognostic Biomarker in Gliomas
Marc Sanson et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A vascular targeted pan phosphoinositide 3-kinase inhibitor prodrug, SF1126, with antitumor and antiangiogenic activity
Joseph R. Garlich et al.
CANCER RESEARCH (2008)
Phosphatidylinostol 3-kinase inhibition broadly sensitizes glioblastoma cells to death receptor- and drug-induced apoptosis
Daniela Opel et al.
CANCER RESEARCH (2008)
microRNA-7 inhibits the epidermal growth factor receptor and the Akt pathway and is down-regulated in glioblastoma
Benjamin Kefas et al.
CANCER RESEARCH (2008)
Urinary biomarkers predict brain tumor presence and response to therapy
Edward R. Smith et al.
CLINICAL CANCER RESEARCH (2008)
Serum α2-HS glycoprotein predicts survival in patients with glioblastoma
Vladimir Petrik et al.
CLINICAL CHEMISTRY (2008)
Transmission of metastatic glioblastoma multiforme from donor to lung transplant recipient
Michael A. Fatt et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2008)
Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector Angiopep-2
Michel Demeule et al.
JOURNAL OF NEUROCHEMISTRY (2008)
Chemokine production and chemokine receptor expression by human glioma cells: Role of CXCL10 in tumour cell proliferation
Seema V. Maru et al.
JOURNAL OF NEUROIMMUNOLOGY (2008)
Persistence of CD133+ cells in human and mouse glioma cell lines:: detailed characterization of GL261 glioma cells with cancer stem cell-like properties
Anhua Wu et al.
STEM CELLS AND DEVELOPMENT (2008)
The 2007 WHO classification of tumours of the central nervous system
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2007)
Neuronal and glioma-derived stem cell factor induces angiogenesis within the brain
LX Sun et al.
CANCER CELL (2006)
Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain
D Zagzag et al.
LABORATORY INVESTIGATION (2005)
Involvement of metalloprotease-2 in the development of human brain microvessels
F Girolamo et al.
HISTOCHEMISTRY AND CELL BIOLOGY (2004)
Tissue factor expression and angiogenesis in human glioma
M Guan et al.
CLINICAL BIOCHEMISTRY (2002)
Inflammation and cancer: back to Virchow?
F Balkwill et al.
LANCET (2001)
Share Paper
